Host responses to Cryptosporidium infection

Journal of Veterinary Internal Medicine

Volumn 16, Issue 1, 2002, Pages 12-21

  Gookin, Jody L ^a   Nordone, Shila K ^a   Argenzio, Robert A ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Cryptosporidiosis; Diarrhea; Immunity; Intestinal epithelium; Pathogenesis

Indexed keywords

ANIMAL; ANIMAL DISEASE; CATTLE; CATTLE DISEASE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; DIARRHEA; HOST PARASITE INTERACTION; IMMUNOLOGY; INTESTINE MUCOSA; MUCOSAL IMMUNITY; PARASITOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SWINE; SWINE DISEASE;

ANIMALS; CATTLE; CATTLE DISEASES; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; DIARRHEA; HOST-PARASITE RELATIONS; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; SWINE; SWINE DISEASES;

EID: 0036358318     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2002.tb01602.x     Document Type: Review

References (88)

1. Current WL. Cryptosporidiosis. J Am Vet Med Assoc 1985;187: 1334-1338.
2. Guerrant RL. Cryptosporidiosis: An emerging, highly infectious threat. Emerg Infect Dis 1997;3.51-57.
3. Division of Child Health and Development. Improving Child Health. IMCI: The Integrated Approach. Geneva, Switzerland: World Health Organization, 1997.
4. MacKenzie WR, Hoxie NJ, Proctor ME. A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply. N Engl J Med 1994;331:161-167.
5. National Dairy Heifer Evaluation Project. Dairy Herd Management Practices Focused on Preweaned Heifers, Part 1. Fort Collins, CO: United States Department of Agriculture and Animal and Plant Health Inspection Service, 1993.
6. DxMonitor Animal Health Report. Etiologic Agents Associated with Calf Diarrhea. Fort Collins, CO: United States Department of Agriculture and Animal and Plant Health Inspection Service; 1992.
7. National Dairy Heifer Evaluation Project. Dairy Heifer Morbidity, Mortality, and Health Management Focusing on Preweaned Heifers: April 1991-July 1992. Fort Collins, CO: United States Department of Agriculture and Animal and Plant Health Inspection Service. 1994.
8. Lopez-Velez R, Tarazona R, Garcia Camacho A, et al. Intestinal and extraintestinal cryptosporidiosis in AIDS patients. Eur J Clin Microbiol Infect Dis 1995;14:677-681.
9. Cosyns M, Tsirkin S, Jones M, et al. Requirement for CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice. Infect Immun 1998;66:603-607.
10. Mead JR, You X. Susceptibility differences to Cryptosporidium parvum infection in two strains of gamma Interferon knockout mice. J Parasitol 1998;84.1045-1048.
11. Stephens J, Cosyns M, Jones M, et al Liver and bile duct pathology following Cryptosporidium parvum infection of immunodeficient mice. Hepatology 1999;30:27-35.
12. Barr SC. Cryptosporidiosis and cyclosporiasis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. Philadelphia. PA: WB Saunders: 1998:518-524.
13. Clark DP. New insights into human cryptosporidiosis. Clin Microbiol Rev 1999;12:554-563.
14. Adams RB, Guerrant RL, Zu S, et al. Cryptosporidium parvum infection of intestinal epithelium: Morphologic and functional studies in an in vitro model. J Infect Dis 1994;169:170-177.
15. Laurent F, Eckmann L, Savidge TC, et al. Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines. Infect Immun 1997;65:5067-5073.
16. Chen XM, LaRusso NF. Mechanisms of attachment and internalization of Cryptosporidium parvum to biliary and intestinal epithelial cells. Gastroenterology 2000;118:368-379.
17. Langer RC, Riggs MW. Cryptosporidium parvum apical complex glycoprotein CSL contains a sporozoite ligand for intestinal epithelial cells Infect Immun 1999;67:5282-5291
18. Nesterenko MV, Woods K, Upton SJ. Receptor/ligand interactions between Cryptospondium parvum and the surface of the host cell. Biochem Biophys Acta 1999;1454:165-173.
19. Joe A, Verdon R, Tzipori S. et al. Attachment of Cryptosporidium parvum sporozoites to human intestinal epithelial cells. Infect Immun 1998;66:3429-3432.
20. Chen XM, Levine SA, Tietz P, et al. Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatology 1998;28:906-913.
21. Marcial MA, Madara JL. Cryptosporidium: Cellular localization, structural analysis of absorptive cell-parasite membrane-membrane interactions in guinea pigs, and suggestion of protozoan transport by M cells. Gastroenterology 1986;90:583-594.
22. Tzipori S, Widmer G. The biology of Cryptosporidium. Contrib Microbiol 2000;6:1-32.
23. Elliott DA, Clark DP. Cryptosporidium parvum induces host cell actin accumulation at the host-parasite interface. Infect Immun 2000; 68:2315-2322.
24. Bonnin A, Lapillonne A, Petrella T, et al. Immunodetection of the microvillus cytoskeleton molecules villin and ezrin in the parasitophorous vacuole wall of Cryptosporidium parvum. Eur J Cell Biol 1999;78:794-801.
25. Forney JR, DeWald DB, Yang S, et al. A role for host phosphoinositide 3-kinase and cytoskeletal remodeling during Cryptosporidium parvum infection. Infect Immun 1999;67:844-852.
26. Parkins ME, Riojas YA, Wu TW, et al. CpABC, a Cryptosporidium parvum ATP-binding cassette protein at the host-parasite boundary in intracellular stages. Proc Natl Acad Sci USA 1999;96: 5734-5739.
27. Argenzio RA, Liacos JA, Levy ML, et al. Villous atrophy, crypt hyperplasia, cellular infiltration, and impaired glucose-Na absorption in enteric cryptosporidiosis of pigs. Gastroenterology 1990;98:1129-1140.
28. Griffiths JK, Moore R, Dooley S, et al. Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death Infect Immun 1994;62:4506-4514.
29. Planchon SM, Martins CAP, Guerrant RL, et al. Regulation of intestinal epithelial barrier function by TGF-β1. Evidence for its role in abrogating the effect of a T cell cytokine. J Immunol 1994;153: 5730-5739.
30. Goodgame RW, Kimball K, Ou CN, et al. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology 1995;108:1075-1082.
31. Moore R, Tzipori S, Griffiths JK, et al. Temporal changes in permeability and structure of piglet ileum after site-specific infection by Cryptosporidium parvum. Gastroenterology 1995;108:1030-1039.
32. +-glucose cotransport. Exp Parasitol 1999;91:119-125.
33. Chen XM, Gores GJ, Paya CV, et al. Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas hgand-dependent mechanism. Am J Physiol 1999;277:G599-G608.
34. McCole DF, Eckmann L, Laurent F, et al. Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection. Infect Immun 2000;68:1710-1713.
35. Seydel KB, Zhang T, Champion GA, et al. Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor alpha and interleukin-8. Infect Immun 1998;66:2379-2382
36. Kandil HM, Berschneider HM, Argenzio RA. Tumor necrosis factor-α changes porcine intestinal ion transport through a paracrine mechanism involving prostaglandins. Gut 1994;35:934-940
37. Argenzio RA, Rhoads JM. Reactive oxygen metabolites in piglet cryptosporidiosis Pediatr Res 1997,41:521-526
38. Guarino A, Canani RB, Casola A, et al. Human intestinal cryptosporidiosis: Secretory diarrhea and enterotoxic activity in Caco-2 cells. J Infect Dis 1995;171:976-983.
39. Kapel N, Huneau JF, Magne D, et al. Cryptosporidiosis-induced impairment of ion transport and Na+-glucose abborption in adult immunocompromised mice J Infect Dis 1997;176.834-837.
40. Argenzio RA, Lecce J, Powell DW. Prostanoids inhibit intestinal NaCl absorption in experimental porcine cryptosporidiosis Gastroenterology 1993,104.440-447.
41. Argenzio RA, Rhoads JM, Armstrong M, et al. Glutamine stimulates prostaglandin-sensitive Na+-H+ exchange in experimental porcine cryptosporidiosis. Gastroenterology 1994;106:1418-1428.
42. Argenzio RA, Armstrong M, Rhoads JM. Role of the enteric nervous system in piglet cryptosporidiosis. J Pharm Exp Ther 1996; 279.1109-1115.
43. Bern MJ, Sturbaum CW, Karayalcin SS, et al. Immune system control of rat and rabbit colonic electrolyte transport. Role of prostaglandins and the enteric nervous system. J Clin Invest 1989;83:1810-1820.
44. 2α production. Infect Immun 1998;66:1787-1790.
45. Moon HW, Kohler EM, Whipp SC. Vacuolation: A function of cell age in porcine ileal absorptive cells. Lab Invest 1973,28:23-28.
46. Cho JH, Musch MW, DePaoli AM, et al. Glucocorticoids regulate Na/H exchange expression and activity in region and tissue-specific manner. Am J Physiol 1994;267:C796-C803
47. 2 and tumor necrosis factor in porcine intestinal inflammation and damage. Gastroenterology 1994;106:A798.
48. Mead JR, Arrowood MJ, Sidwell RW, et al. Chronic Cryptosporidium parvum infection in congenitally immunodeficient SCID and nude mice. J Infect Dis 1991;163:1297-1304.
49. McDonald V, Deer R, Uni S, et al. Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice. Infect Immun 1992;60:3325-3331.
50. Kuhls TL, Greenfield RA, Mosier DA, et al. Cryptosporidiosis in adult and neonatal mice with severe combined immunodeficiency. J Comp Pathol 1992;106:399-410.
51. Rohlman VC, Kuhis TL, Mosier DA, et al. Cryptosporidium parvum infection after abrogation of natural killer cell activity in normal and severe combined immunodeficient mice. J Parasitol 1993;79: 295-297.
52. Chai J-Y, Guk S-M, Han H-K, et al. Role of intraepithelial lymphocytes in mucosal immune responses of mice experimentally infected with Cryptosporidium parvum. J Parasitol 1999;85:234-239.
53. Culshaw RJ, Bancroft GJ, McDonald V Gut intraepithelial lymphocytes induce immunity against Cryptosporidium infection through a mechanism involving gamma interferon production. Infect Immun 1997;65:3074-3079.
54. Taghi-Kilani R, Sekla L, Hayglass KT. The role of humoral immunity in Cryptosporidium spp. infection Studies with B cell-depleted mice. J Immunol 1990;145:1571-1576.
55. Perryman LE, Mason PH. Chrisp CE. Effect of spleen cell populations on resolution of Cryptosporidium parvum infection in SCID mice. Infect Immun 1994;62 1474-1477.
56. Waters WR, Harp JA. Cryptosporidium parvum in T-cell receptor (TCR)-α- and TCR-δ-deficient mice. Infect Immun 1996;64: 1854-1857.
57. Aguirre SA, Mason PH. Perryman LE. Susceptibility of major histocompatibility complex (MHC) class I- and MHC class II-deficient mice to Cryptosporidium parvum infection. Infect Immun 1994;62: 697-699.
58. McDonald V, Robinson HA, Kelly JP, et al. Immunity to Cryptosporidium muris infection in mice is expressed through gut CD4+ intraepithelial lymphocytes. Infect Immun 1996;64:2556-2562.
59. Wyatt CR, Brackett EJ, Perryman LE, et al. Activation of intestinal intraepithelial T lymphocytes in calves infected with Cryptosporidium parvum Infect Immun 1997;65.185-190.
60. Wyatt CR, Brackett EJ, Barrett WJ. Accumulation of mucosal T lymphocytes around epithelial cells after in vitro infection with Cryptosporidium parvum J Parasitol 1999;85:765-768.
61. Adjei AA, Curran BC, Castro M, et al. γδ+ T cells and 65-kDa heat shock protein expression following Cryptosporidium parvum challenge in athymic C57BL/6J nude mice. Immunol Lett 2000;72. 35-38.
62. Waters WR, Harp JA, Nonnecke BJ. Phenotypic analysis of peripheral blood lymphocytes and intestinal intra-epithelial lymphocytes in calves. Vet Immunol Immunopathol 1995;48:249-259.
63. + T lymphocytes in protective immunity. J Immunol 1991;147:1014-1022.
64. Chen W, Harp JA, Harmsen AG. Requirements for CD4+ cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice. Infect Immun 1993;61:3928-3932.
65. Chen W, Harp JA, Harmsen AG, et al. Gamma interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice. Infect Immun 1993;61:3548-3551.
66. Enriquez FJ, Sterling CR. Role of CD4+ Th1- and Th2-cell secreted cytokines in cryptosporidiosis. Fol Parasitol 1993;40:307-311.
67. Urban JF, Payer R, Chen SJ, et al. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J Immunol 1996;156:263-268.
68. Aguirre SA, Perryman LE, Davis WC, et al. IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: Analysis of CD4+αβ+IFN-γ+ and CD4+αβ+IL-4-+ lymphocytes in gut-associated lymphoid tissue during resolution of infection J Immunol 1998;161:1891-1900.
69. Lukin K, Cosyns M, Mitchell T, et al. Eradication of Cryptosporidium parvum infection by mice with ovalbumin-specific T cells. infect Immun 2000;68:2663-2670.
70. Griffiths JK, Theodos C, Paris M, et al. The gamma interferon gene knockout mouse: A highly sensitive model for evaluation of therapeutic agents against Cryptosporidium parvum. J Clin Microbiol 1998;36.2503-2508
71. You X, Mead JR. Characterization of experimental Cryptosporidium parvum infection in IFN-γ knockout mice Parasitology 1998, 117:525-531.
72. Colgan SP, Parkos CA, Matthews JB, et al. Interferon-γ induces a cell surface phenotype switch on T84 intestinal epithelial cells Am J Physiol 1994;267:C402-C410.
73. Müerköster S, Laman JD, Rocha M, et al. Functional and in situ evidence for nitric oxide production driven by CD40-CD40L interactions in graft-versus-leukemia reactivity. Clin Cancer Res 2000; 6:1988-1996.
74. Pollok RC, Farthing MJ, Bajaj-Elliott M, et al. Cellular mechanisms of Interferon γ mediated inhibition of Cryptosporidium parvum infection. Gastroenterology 2000;118:A817.
75. x generation by cultured small intestinal epithelial cells. Dig Dis Sci 1995;40:1859-1865.
76. Foy TM, Aruffo A, Bajorath J, et al. Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 1996;14:591-617.
77. Leitch GJ, He Q. Reactive nitrogen and oxygen species ameliorate experimental cryptospondiosis in the neonatal BALB/c mouse model. Infect Immun 1999;67:5885-5891.
78. Leitch GJ, He Q. Arginine-derived nitric oxide reduces fecal oocyst shedding in nude mice infected with Cryptosporidium parvum Infect Immun 1994;62:5173-5176.
79. Hayward AR, Chmura K, Cosyns M. Interferon-γ is required for innate immunity to Cryptosporidium parvum in mice. J Infect Dis 2000;182:100-1004.
80. Kuhls TL, Mosier DA, Abrams VL, et al. Inability of interferon-gamma and aminoguamdine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency. J Parasitol 1994;80.480-485.
81. James SL. Role of nitric oxide in parasitic infections. Microbiol Rev 1995;59:533-547.
82. Eckmann L, Laurent F, Langford TD, et al. Nitric oxide production by human intestinal epithelial cells and competition for arginine as potential determinants of host defense against the lumen-dwelling pathogen Giardia lamblia. J Immunol 2000;164:1478-1487.
83. Brune B, von Knethen A, Sandau KB Nitnc oxide and its role in apoptosis Eur J Pharmacol 1998;351:261-272.
84. Miller MJS, Thompson JH, Zhang X-J, et al. Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis. Gastroenterology 1995;109:1475-1483.
85. Theodos CM, Sullivan KL, Griffiths JK, et al. Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: The extent of gamma Interferon modulation determines the outcome of infection. Infect Immun 1997;65:4761-4769.
86. Smith LM, Bonafonte MT, Mead JR. Cytokine expression and specific lymphocyte proliferation in two strains of Cryptosporidium parvum-infected gamma-interferon knockout mice. J Parasitol 2000; 86:300-307
87. Bellamy R. The natural resistance-associated macrophage protein and susceptibility to intracellular pathogens. Microbes Infect 1999;1:23-27.
88. Feng J, Li Y, Hashad M, et al. Bovine natural resistance associated macrophage protein 1 (Nramp1) gene. Genome Res 1996;6: 956-964.